NKTR
Nektar Therapeutics
NASDAQ · Healthcare · Biotechnology · US
$74.19
−2.85%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -1.01x
- Net debt / EBITDA
- -0.72x
Liquidity & coverage
- Current ratio
- 10.42x
- Quick ratio
- 10.42x
- Cash ratio
- 9.64x
- Interest coverage
- -4.24x
- EBITDA / interest
- -4.34x
- Working capital
- $668.4M
Cash & dividend
- FCF / debt
- -1.72x
- Cash flow / debt
- -1.72x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026